As the coronavirus resurges in Japan, politicians and experts are growing more divided on the impact that a subsidy program encouraging people to travel is having on the spread of Covid-19. AstraZeneca Plc’s Covid-19 vaccine looks like it’s headed for an additional global trial as the drugmaker tries to clear up uncertainty and confusion surrounding favorable results in its current study.
New infections in New York reached a seven-month high, while hospitalizations rose to their highest level since June. In Europe, the total number of cases in Germany topped 1 million, and the number of patients in intensive care rose to record levels. Chancellor Angela Merkel urged Germans to do more to rein in the pandemic and called on Europe’s ski resorts to close.
Elsewhere, London will avoid the toughest coronavirus restrictions when England’s partial lockdown ends next week, the number of severely ill French patients in intensive care fell to the lowest level in more than three weeks. Argentines mourning the death of soccer icon Diego Maradona ignored virus restrictions.
Global Tracker: Cases top 60.8 million; deaths top 1.4 millionBiden warns of ‘long, hard winter’ for virus in somber addressLondon avoids toughest curbs as Tories protestAirline claims that flying is safe stir doubts among expertsThe best and the worst places to be in the coronavirus eraCovid vaccine rush in China raises fears of booming black market
Subscribe to a daily update on the virus from Bloomberg’s Prognosis team here. Click CVID on the terminal for global data on coronavirus cases and deaths.
Debate Erupts Over Japan Travel Campaign (10 a.m. HK)
As the coronavirus resurges in Japan, politicians and experts are growing more divided on the impact that a subsidy program encouraging people to travel is having on the spread of Covid-19.
The popular “Go To Travel” campaign, which discounts trips to boost regions hit hardest by a lack of tourists, is one of the government’s most prized projects for spurring the economy, and has been heavily backed by Prime Minister Yoshihide Suga.
U.K. Moves to Get Vaccine Approved Before EU (8:03 a.m. HK)
Health Secretary Matt Hancock asked the U.K. medical regulator to potentially bypass its European Union counterpart and approve the supply of AstraZeneca Plc’s Covid vaccine to speed its deployment.
AstraZeneca Eyes Extra Global Vaccine Trial (8:02 a.m. HK)
AstraZeneca Plc’s Covid-19 vaccine looks like it’s headed for an additional global trial as the drugmaker tries to clear up uncertainty and confusion surrounding favorable results in its current study.
The company wants the new test to confirm the 90% efficacy rate that the shot showed in a portion of an existing trial, Chief Executive Officer Pascal Soriot said. It’s favoring that option rather than adding an arm to a separate study that’s already underway in the U.S.
California’s Positive-Test Rate Hits 6.1% (6:15 p.m. NY)
California reported 14,640 new cases on Thursday, bringing the total for the state to